TPG will sell its equity interest in OneOncology to Cencora, according to a news release.
OneOncology, founded in 2018 and based in Nashville, Tennessee, is a partnership of independent community oncology practices.
TPG, founded in 1992 and based in San Francisco, targets investments in middle market companies. The firm invests in healthcare and a number of other industries.
Cencora, formerly AmerisourceBergen, is a global pharmaceutical solutions organization.
Terms of the transaction were not disclosed.
